165 related articles for article (PubMed ID: 3167228)
1. Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model.
Osborne CK; Ross CR; Coronado EB; Fuqua SA; Kitten LJ
Breast Cancer Res Treat; 1988 Jul; 11(3):211-9. PubMed ID: 3167228
[TBL] [Abstract][Full Text] [Related]
2. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.
Jordan VC; Gottardis MM; Robinson SP; Friedl A
J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
Robinson SP; Jordan VC
Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
[TBL] [Abstract][Full Text] [Related]
4. Regulation of estrogen receptor and epidermal growth factor receptor by tamoxifen under high and low estrogen environments in MCF-7 cells grown in athymic mice.
Koibuchi Y; Iino Y; Uchida T; Andoh T; Horii Y; Nagasawa M; Horiguchi J; Maemura M; Takei H; Yokoe T; Morishita Y
Oncol Rep; 2000; 7(1):135-40. PubMed ID: 10601607
[TBL] [Abstract][Full Text] [Related]
5. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
6. Similarities and differences in the ultrastructure of two hormone-dependent and one independent human breast carcinoma grown in athymic nude mice: comparison with the rat DMBA-induced tumor and normal secretory mammocytes.
Anderson WA; Perotti ME; McManaway M; Lindsey S; Eckberg WR
J Submicrosc Cytol; 1984 Oct; 16(4):673-90. PubMed ID: 6438351
[TBL] [Abstract][Full Text] [Related]
7. IGF-I and IGF-II expression in human breast cancer xenografts: relationship to hormone independence.
Brünner N; Moser C; Clarke R; Cullen K
Breast Cancer Res Treat; 1992; 22(1):39-45. PubMed ID: 1421423
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status.
Clemmons DR; Camacho-Hubner C; Coronado E; Osborne CK
Endocrinology; 1990 Dec; 127(6):2679-86. PubMed ID: 1701124
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: blockage of the paracrine effect and receptor binding of transforming growth factor beta1 and platelet-derived growth factor-BB.
Bagheri-Yarmand R; Kourbali Y; Morère JF; Jozefonvicz J; Crépin M
Cell Growth Differ; 1998 Jun; 9(6):497-504. PubMed ID: 9663468
[TBL] [Abstract][Full Text] [Related]
10. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.
Bates SE; Davidson NE; Valverius EM; Freter CE; Dickson RB; Tam JP; Kudlow JE; Lippman ME; Salomon DS
Mol Endocrinol; 1988 Jun; 2(6):543-55. PubMed ID: 3047554
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
[TBL] [Abstract][Full Text] [Related]
12. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice.
Schafer JM; Lee ES; O'Regan RM; Yao K; Jordan VC
Clin Cancer Res; 2000 Nov; 6(11):4373-80. PubMed ID: 11106256
[TBL] [Abstract][Full Text] [Related]
13. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer.
Yi B; Williams PJ; Niewolna M; Wang Y; Yoneda T
Cancer Res; 2002 Feb; 62(3):917-23. PubMed ID: 11830552
[TBL] [Abstract][Full Text] [Related]
15. Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.
Sirbasku DA; Moreno-Cuevas JE
In Vitro Cell Dev Biol Anim; 2000; 36(7):428-46. PubMed ID: 11039494
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
Arteaga CL; Osborne CK
Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Med Oncol; 2005; 22(2):129-38. PubMed ID: 15965275
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and oncogene mediated growth regulation of human breast cancer cells.
Kasid A; Lippman ME
J Steroid Biochem; 1987; 27(1-3):465-70. PubMed ID: 3501040
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
[TBL] [Abstract][Full Text] [Related]
20. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
